Latest News and Press Releases
Want to stay updated on the latest news?
-
Studieresultater viser, at Coloplasts nye engangskateter med mere end 80 mikrohuller, Luja, opnåede fuldstændig blæretømning i frit flow* i 90% af kateteriseringerne, mens Hollister’s VaPro™ med to...
-
Study results show that Coloplast’s new intermittent male catheter with 80+ micro-holes, Luja, achieved complete bladder emptying in one free flow* in 90% of catheterisations, while Hollister’s...
-
Det nye intermitterende kateter, Luja™, adresserer betydelige risikofaktorer for urinvejsinfektioner, som er en byrde for mennesker, der bruger intermitterende katetre samt sundhedssystemer verden...
-
The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a...
-
Coloplast’s SpeediCath® Flex Set catheter developed for people living with bladder and urinary problems is now cleared in the U.S. and will be launched in November 2022. The new SpeediCath Flex Set...
-
Den 2. januar 2023 overtager Tommy Johns stillingen som ansvarlig for Coloplasts globale urologiforretning. Tommy Johns tager over efter Steve Blum, der har besluttet at gå på pension ved dette års...
-
Effective January 2, 2023, Tommy Johns will enter a new role as President & Senior Vice President of Coloplast’s global Interventional Urology (IU) business, replacing Steve Blum, who has decided...
-
Coloplast is introducing the Saffron™ Fixation System designed for ease and reliability during pelvic floor reconstruction for women who suffer from pelvic organ prolapse (POP). “Our goal...
-
Forventningerne til den rapporterede vækst og den rapporterede overskudsgrad før særlige poster fastholdes på hhv. omkring 15% og omkring 31%. Den rapporterede omsætning målt i danske kroner steg 16%...
-
The company maintains its reported growth guidance of around 15% and reported EBIT margin guidance of around 31% before special items. Reported revenue in DKK was up by 16% in Q2. EBIT before special...